A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study. Imamura, Fumiaki; Sharp, Stephen J.; Koulman, Albert; Schulze, Matthias B.; Kröger, Janine; Griffin, Julian L.; Huerta, José M.; Guevara, Marcela; Sluijs, Ivonne; Agudo, Antonio; Ardanaz, Eva; Balkau, Beverley; Boeing, Heiner; Chajes, Veronique; Dahm, Christina C.; Dow, Courtney; Fagherazzi, Guy; Feskens, Edith J. M.; Franks, Paul W.; Gavrila, Diana; Gunter, Marc; Kaaks, Rudolf; Key, Timothy J.; Khaw, Kay-Tee; Kühn, Tilman; Melander, Olle; Molina-Portillo, Elena; Nilsson, Peter M.; Olsen, Anja; Overvad, Kim; Palli, Domenico; Panico, Salvatore; Rolandsson, Olov; Sieri, Sabina; Sacerdote, Carlotta; Slimani, Nadia; Spijkerman, Annemieke M. W.; Tjønneland, Anne; Tumino, Rosario; van der Schouw, Yvonne T.; Langenberg, Claudia; Riboli, Elio; Forouhi, Nita G.; Wareham, Nick J.. PLoS medicine. 2017; 14: p.e1002409. doi:10.1371/journal.pmed.1002409Article
Épidémiologie clinique